Joo-yong Hahn, MD, PhD
Samsung Medical Center
14
7
2
N/A
0
9
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+18 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (14)
Showing 10 of 14 trials
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Bon-Kwon Koo, MD, PhD
Seoul National University Hospital
Shared therapeutic areas:
Worked with same sponsors:
Joo Myung Lee, MD, MPH, PhD
Samsung Medical Center
Shared therapeutic areas:
Worked with same sponsors:
Young Joon Hong, MD, PhD
Chonnam National University
Shared therapeutic areas:
Worked with same sponsors:
Young Bin Song, MD, PhD
Samsung Medical Center
Shared therapeutic areas:
Worked with same sponsors:
Ron Waksman, MD
Medstar Health Research Institute
Shared therapeutic areas:
Amir Lerman, MD
Mayo Clinic
Shared therapeutic areas:
Andrea Natale, MD
Texas Cardiac Arrhythmia Research Foundation
Shared therapeutic areas:
Hyo-soo Kim, MD, PhD
Seoul National University Hospital
Shared therapeutic areas:
Worked with same sponsors:
Yundai Chen, M.D.
Chinese PLA General Hospital
Shared therapeutic areas:
loic MONDOLONI
Assistance Publique Hopitaux De Marseille
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (14)
Showing 14 of 14 trials
Net Clinical Benefit of Edoxaban Versus Apixaban in Patients With Atrial Fibrillation and Coronary Artery Disease
Drug-Coated Balloon Versus Drug-Eluting Stent for Treatment of De-Novo Coronary Lesions in Patients With High Bleeding Risk-2
OCT Versus Angiography for Culprit Lesion Revascularization in Acute Myocardial Infarction PatiEnts
IVUS Versus FFR for Non-infarct Related Artery Lesions in Patients With Multivessel Disease and Acute MI
CHoice of Optimal Anti-Thrombotic Strategy in Patients Undergoing Implantation of Coronary Drug-Eluting Stents 4
SMart Angioplasty Research Team: CHoice of Optimal Anti-Thrombotic Strategy in Patients Undergoing Implantation of Coronary Drug-Eluting Stents 3
Aspirin and a PoTent P2Y12 Inhibitor Versus Aspirin and Clopidogrel in Patients Undergoing PCI for Complex Lesion
Intravascular Imaging- Versus Angiography-Guided Percutaneous Coronary Intervention For Complex Coronary Artery Disease
Randomized Controlled Trial of Moderate-Intensity Rosuvastatin With Ezetimibe Combination Therapy Versus High-Intensity Rosuvastatin on Progression of Coronary Atherosclerotic Plaque
P2Y12 Inhibitor Monotherapy Versus Extended DAPT in Patients Treated With Bioresorbable Scaffold
DEB Versus 2nd Generation DES in Patients With In-Scaffold Restenosis of Bioresorbable Vascular Scaffold
Registry of Comprehensive Imaging and Physiological Evaluation of Deferred Lesions Based on FFR
FFR Versus Angiography-Guided Strategy for Management of AMI With Multivessel Disease
Genotype-Guided Abbreviated DAPT Versus Un-Guided De-escalation Therapy in Patients With ACS and HBR
All 14 trials loaded